Newsroom

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Rising Dividend Achievers UCITS ETF 28.04.2026 RDVY LN IE000K5F6EL4 875,002.00 USD 20,633,482.01 23.581  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust SMID Rising Dividend Achievers UCITS ETF 28.04.2026 SDVI.LN IE000YVOQ2A3 40,361.00 USD 1,155,075.93 28.619  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust SMID Rising Dividend Achievers UCITS ETF 28.04.2026 SDVY.LN IE0001R850E1 14,429,007.00 USD 363,746,715.57 25.209  ...

PARMA, Italy & FRAMINGHAM, Mass.--(BUSINESS WIRE)--Chiesi Group (“Chiesi”), an international research-focused biopharmaceutical group and certified B Corp, and KalVista Pharmaceuticals, Inc. (“KalVista”) (Nasdaq: KALV), today announced that the companies have entered into a definitive agreement under which Chiesi will acquire KalVista (the “Transaction”). The Transaction was unanimously approved by both Chiesi’s and KalVista’s Boards of Directors and is expected to close in Q3 2026, subject to...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Growth Strength UCITS ETF 28.04.2026 FTGS.LN IE000YZLMXT9 25,002.00 USD 562,373.73 22.493  ...

MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Le partenaire de Medincell (Euronext Paris : MEDCL), Teva Pharmaceuticals (NYSE et TASE : TEVA), a annoncé aujourd’hui que les ventes nettes de UZEDY aux Etats-Unis ont atteint 63 millions de dollars au premier trimestre 2026. Ce résultat représente une progression de +62% par rapport aux 39 millions de dollars enregistrés au premier trimestre 2025 et de +15 % par rapport aux ventes de 55 millions de dollars au quatrième trimestre 2025. Med...

MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Medincell (Euronext Paris: MEDCL) partner, Teva Pharmaceuticals (NYSE and TASE: TEVA), announced today that UZEDY U.S. net sales reached $63 million in Q1 2026, representing a 62% increase from $39 million in Q1 2025 and a 15% increase from $55 million in Q4 2025. Medincell receives mid‑ to high‑single-digit royalties on UZEDY net sales and is eligible for up to $105M in commercial milestone payments, subject to the achievement of annual sa...

GRENOBLE--(BUSINESS WIRE)--Regulatory News: SAMSE (Paris:SAMS) informe ses actionnaires qu’une Assemblée Générale Mixte se tiendra le Jeudi 21 mai 2026 à 14 heures au siège social de la société. L’avis de réunion valant avis de convocation a été publié au Bulletin des Annonces Légales et Obligatoires (BALO) le 15 avril 2026. L’avis de convocation, qui contient notamment l’ordre du jour de cette Assemblée et les projets de résolutions qui lui seront soumis ainsi que les modalités de participatio...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Moderate Buffer UCITS ETF - February 28.04.2026 GFEB.LN IE000X8M8M80 700,002.00 USD 26,835,460.73 38.336  ...

HYDERABAD, India & MISSISSAUGA, Ontario--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. announced that it has received a Notice of Compliance (NOC) from Health Canada for its generic Semaglutide Injection....